Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Early overnutrition reduces Pdx1 expression and induces β cell failure in Swiss Webster mice

Abstract

Childhood obesity and early rapid growth increase the risk for type 2 diabetes. Such early overnutrition can be modeled in mice by reducing litter size. We investigated the effects of early overnutrition and increased dietary fat intake on β cell function in Swiss Webster mice. On a moderate-fat diet, early overnutrition accelerated weight gain and induced hyperinsulinemia in pups. Early overnutrition males exhibited higher β cell mass but reduced islet insulin content and Pdx1 expression. Males had a high diabetes incidence that was increased by early overnutrition, characterized by a progressive increase in insulin secretion as well as β cell death, indicated by histological analysis and increased circulating miR-375 levels. Females maintained normoglycemia throughout life. High-fat diet (HFD) increased diabetes incidence in males, whereas low-fat diet was completely protective. This protective effect was abolished in early overnutrition males transiently exposed to HFD in early life. Although Swiss Webster mice are not known to be diabetes-prone, the high diabetes incidence suggests an underlying genetic susceptibility that can be induced by overnutrition and increased dietary fat intake in early life. Thus, the nutritional environment in early life may impact long-term β cell function and increase diabetes risk, particularly in genetically susceptible individuals.

Introduction

A major risk factor for obesity and type 2 diabetes is prolonged overnutrition, particularly with an obesogenic diet. In addition, evidence from epidemiological and animal studies suggests that an adverse in utero and early postnatal environment can increase the risk of type 2 diabetes1,2,3,4,5,6,7,8. Maternal obesity, high energy diet, and hyperglycemia during pregnancy have all been implicated in increased offspring diabetes risk9,10. Although it is difficult to investigate postnatal risk factors in humans without the confounding effects of in utero environment differences, both human and animal studies have noted increased diabetes risk with increased infant adiposity, early rapid growth, accelerated catch-up growth following intrauterine growth restriction (IUGR), and childhood obesity2,11,12,13. These observations suggest that the early developmental environment can have long-term effects on glucose homeostasis and ultimately contribute to disease. However, the effects of early overnutrition alone on the development of β cells and glucose homeostasis are unclear.

In humans, β cell mass rapidly increases after birth, with the greatest rate of expansion occurring before 2–5 years of age and the highest rate of β cell replication up to 2 months of age14. A similar pattern of postnatal expansion is observed in mice, with the highest rate of β cell mass expansion between birth and weaning, and peak β cell replication at 9 days of age15. It has been speculated that this early β cell mass expansion during infancy and childhood prepares the individual to cope with the metabolic demands of puberty and adulthood14. Consequently, insults that impair postnatal β cell mass expansion or functional development may reduce the capacity to meet later metabolic demands, leading to diabetes.

We investigated the effects of early overnutrition on β cells by employing a mouse model of early overnutrition, induced by reducing litter size, which reduces competition for maternal milk. Numerous studies have demonstrated that in rodents, this model results in accelerated body weight gain and adiposity in pups, with some studies showing alterations in glucose homeostasis, although phenotype varies by species and strain16,17,18,19,20,21,22. However, the effects of early overnutrition and dietary fat in early life on β cell development have not been thoroughly examined. In the Swiss Webster mouse, reduced litter size has previously been shown to increase susceptibility to HFD-induced obesity and insulin resistance20. We hypothesized that overnutrition and increased dietary fat intake during the early postnatal period in Swiss Webster mice would adversely affect β cell development and long-term function.

Results

Early Overnutrition in Pups Alters Body Composition and β Cell Mass

In both male and female pups (Fig. 1a,b), early overnutrition resulted in increased body weight gain such that early overnutrition pups weighed significantly more than control pups beginning at postnatal day (P) 10 through weaning at P21. Early overnutrition male pups exhibited elevated non-fasted insulin (Fig. 1c) and leptin (Fig. 1d) levels at P11, as well as increased non-fasted blood glucose levels at P14 and P21 (Fig. 1e). In addition, early overnutrition male pups had increased adiposity at P14 and P21, demonstrated by increased mass of the epididymal, retroperitoneal, and mesenteric fat pads, even when normalized to body weight (Fig. 1f, Table 1). Full stomach weight (Fig. 1g) was significantly increased at P14 in early overnutrition vs control male pups, reflecting their increased milk intake since the weight was mainly due to the stomach contents. Early overnutrition pups exhibited higher pancreas, liver, kidney, and spleen weight as well as body length at P14 (Table 1), suggesting a more rapid growth rate. β cell mass was significantly increased in early overnutrition male pups at P14 (Fig. 1h,i) even when normalized to body weight. However, total pancreas insulin content (Fig. 1j) measured at P21 did not differ between early overnutrition and control male pups.

Figure 1
figure1

Effects of early overnutrition in pups. Body weight in male (a) and female (b) pups from postnatal day (P) 2 until weaning at P21 (n = 18–19 for males, n = 7–8 for females). Non-fasted plasma insulin (c) and plasma leptin (d) in P11 males. Non-fasted blood glucose (e), epididymal white adipose tissue (eWAT) weight (f), and full stomach weight (g) in P10, 14, and 21 male pups. β cell mass (h) and β cell mass normalized to body weight (i) in P14 male pups. Pancreatic insulin content (j) in P21 male pups. Data in (a) and (b) represent median ± interquartile range. Box and whisker plots (cg, j) represent the interquartile range (box) and minimum to maximum values (whiskers), with line at the median. Floating bars (h,i) represent the range of values with line at the median. Analyses by two-way repeated measures ANOVA with Bonferroni post-hoc (a,b), two-way ANOVA with Bonferroni post-hoc (eg), or unpaired t-test (c,d,hj); *p < 0.05, ***p < 0.0005.

Table 1 Tissue weights in postnatal day (P) 14 and P45 male mice.

Glucose and Insulin Tolerance in Adults

Both early overnutrition males and females maintained a small but significant increase in body weight, relative to their control counterparts, post-weaning and into adulthood (Fig. 2a,b). However, food intake did not differ (median (interquartile range; IQR) of daily caloric intake in control: 0.55 (0.52–0.65) kcal/g body weight, n = 7; early overnutrition: 0.53 (0.50–0.59) kcal/g body weight, n = 8; p = 0.141 by unpaired t-test, measured in males only). Plasma leptin did not differ in males at P60 (Fig. 2c). However, early overnutrition males had elevated plasma triglyceride levels at P50 (Fig. 2d) and a higher incidence of diabetes (Fig. 2e) compared to control males, with earliest onset of diabetes at 11 weeks of age, characterized by hyperglycemia, polyuria, and polydipsia. In contrast, females did not develop diabetes and maintained normal fasting glucose levels to P171 (median (IQR) in control: 6.8 (6.3–7.6) mmol/L; early overnutrition: 7.2 (6.5–7.7) mmol/L, p = 0.48 by unpaired t-test). Intraperitoneal glucose tolerance tests performed at P58, when no mice were diabetic, demonstrated no statistically significant differences in glucose or insulin responses between early overnutrition and control males (Fig. 2f–i). Although there was a trend toward increased glucose responses at this age, oral glucose tolerance tests in a separate cohort of mice showed no differences in glucose responses at P44 or P77 (Supplementary Fig. S1). In addition, early overnutrition and control males showed similar glucose responses during insulin tolerance tests at P85 (Fig. 2j,k), suggesting comparable degrees of insulin sensitivity.

Figure 2
figure2

Glucose and insulin tolerance in adults. Body weight in males (a) to postnatal day (P) 71 (n = 15–16) and females (b) to P171 (in females, main effect of group with early overnutrition > control by two-way repeated measures ANOVA, p < 0.05; n = 7–8). Plasma leptin levels (c) and plasma triglyceride levels (d) at P50 in males, and diabetes incidence (e) in males to 52 weeks of age (p = 0.021 by log-rank test). Blood glucose response (f), glucose AUC (g), plasma insulin response (h), and insulin AUC (i) after intraperitoneal injection of 2 g/kg of glucose in 6 hr fasted male mice at P58. Blood glucose response normalized to baseline (j) and glucose AUC (k) in response to intraperitoneal injection of 0.75 U/kg insulin (Novolin) in 4 hr fasted male mice at P85. Data in (a,b,f,h and j) represent median ± interquartile range. Box and whisker plots (c,d,g,i,k) represent the interquartile range (box) and minimum to maximum values (whiskers), with line at the median. AUC: area under the curve with baseline = 0. Analyses by two-way repeated measures ANOVA with Bonferroni post-hoc (a,b) or unpaired t-test (c); *p < 0.05, **p < 0.005.

Islets in Non-Diabetic Adult Mice

To investigate the effects of early overnutrition on β cell mass in adults, we examined insulin stained pancreas sections in non-diabetic males. Early overnutrition males exhibited significantly increased β cell mass at P100 compared to control males, even when normalized to body weight (Fig. 3a). This was due to an increase in the number of islets (Fig. 3b), whereas islet size distribution did not differ between early overnutrition and control (Fig. 3c). Isolated islets from non-diabetic mice showed similar responses to basal (3 mM) and high (20 mM) glucose levels and in response to 30 mM KCl depolarization (Fig. 3d). However, early overnutrition islets exhibited less insulin per islet (Fig. 3e). Total pancreas insulin content did not differ between early overnutrition and control mice (Fig. 3f), likely due to the reduced insulin content per islet despite the larger islet number in early overnutrition mice. To identify early alterations in β cells that may contribute to progressive dysfunction, we examined gene expression in islets from young (P50) non-diabetic mice. We observed no differences in islet mRNA expression of insulin 1 (Ins1), insulin 2 (Ins2), or insulin receptor (Insr) between early overnutrition and control males (Fig. 3g). However, gene expression of the key β cell transcription factor Pdx1 was significantly decreased in early overnutrition vs control islets, with no difference in the β cell-enriched transcription factors Foxo1, Nkx6-1, and Mafa. Neurod1 was marginally reduced in early overnutrition mice but did not reach a statistically significant difference (p = 0.0549). Genes that have been shown to be important in β cell lipotoxicity, endoplasmic reticulum (ER) stress, and oxidative stress (Srebp1c, Ucp2, Plin2, Ddit3, and Nos2)23,24,25,26,27 did not differ between early overnutrition and control islets (Fig. 3h).

Figure 3
figure3

Islets in non-diabetic adult mice. β cell mass normalized to body weight (a), number of islets normalized to pancreas area (b), and islet size distribution (c) measured by insulin-positive area per islet, in non-diabetic early overnutrition vs control males at postnatal day (P) 100. Insulin secretion (d) of 80 size-matched isolated islets per mouse perifused with glucose (3 and 20 mM) and KCl (30 mM) at P80. Insulin content per islet (e) averaged from 5 size-matched islets per mouse at P94, and total pancreas insulin content (f) at P88. Expression of genes important for β cell function (g) and genes implicated in β cell lipotoxicity (Srebp1c, Ucp2, Plin2), endoplasmic reticulum stress (Ddit3, Plin2), and oxidative stress (Nos2) (h) in islets isolated at P50. Box and whisker plots (ac,f-h) represent the interquartile range (box) and minimum to maximum values (whiskers), with line at the median. Line graph (d) represents median ± interquartile range. Floating bars (e) represent the range of values with line at the median. Analyses by unpaired t-tests (for a,b,e), or unpaired t-test with Bonferroni correction for multiple comparisons (g); *p < 0.05.

Early Overnutrition and β cell Death in Male Mice

To determine whether diabetes in early overnutrition mice was due to increased apoptosis of β cells, we quantified insulin immunoreactive cells that colocalized with cleaved caspase-3, a specific marker for cells undergoing apoptosis28. Diabetes induced an increase in cleaved caspase-3-positive β cells (Fig. 4a,b), suggesting that β cell death by apoptosis contributed to diabetes progression. To better assess the dynamics of β cell death relative to disease onset, we measured circulating miR-375, a marker of β cell death29,30, once a week and compared it to glucose levels. In early overnutrition male mice, fasting glucose was stable in the weeks prior to diabetes (Fig. 4c,f), yet miR-375 was increased in the 2 weeks prior to diabetes onset (Fig. 4d,e). The peak of circulating miR-375 levels (Fig. 4e) varied among individual mice from −2 to 0 weeks relative to diabetes onset (age of onset ranged from P51 to P116), and levels dropped in the week following diabetes onset. To further assess the status of β cells in relation to diabetes onset, we measured both insulin and proinsulin levels in the same mice prior and following diabetes onset (Fig. 4g,h). Due to the large plasma volume required for measuring miR-375 levels, there was not sufficient plasma to measure these hormones at the same timepoints as miR-375 (i.e., −4 to 1 week relative to diabetes onset). Nonetheless, we observed that in individual mice both insulin and proinsulin rose prior to diabetes onset, suggesting progressive β cell dysfunction, and declined following diabetes onset, likely as a consequence of the β cell death indicated by a rise in circulating miR-375 levels. We did not observe a change in the proinsulin/insulin ratio over time (data not shown), suggesting that processing of proinsulin to insulin remained stable. Plasma triglyceride levels were stable in the weeks prior to diabetes onset (data not shown) but were significantly elevated in diabetic mice as expected (Fig. 4i).

Figure 4
figure4

β cell death in male Swiss Webster mice. Cytoplasmic cleaved caspase 3 staining (a, red) was rarely observed in insulin (green) positive cells in young (5 week) non-diabetic early overnutrition males but levels were increased in recently diabetic early overnutrition males (14 week; double-labeled insulin and cleaved caspase-3 cell indicated by white arrow). This was quantified (b) and normalized to β cell area, determined as the area in mm2 of positive insulin immunoreactivity per section (**p < 0.01 by unpaired t-test). Diabetes induced by early overnutrition resulted in elevated blood glucose (c) at 0 and 1 week compared to −4 weeks relative to diabetes onset (***p < 0.001 by one-way ANOVA). Levels of miR-375 (d) in plasma (normalized to miR-16*) were increased at −2 and −1 week compared to −4 weeks relative to diabetes onset (*p < 0.05 by one-way ANOVA). Gaussian distribution fit (e) of miR-375 plasma levels (normalized to miR-16*) in individual mice showing peak miR-375 levels ranging from −2 to 0 weeks relative to diabetes onset (unpaired t-test of mean amplitude relative to 0: p < 0.05). Fasting (4 hr) blood glucose (f), plasma insulin (g), and plasma proinsulin (h) levels in individual mice before and after diabetes onset. Both insulin and proinsulin increased prior to diabetes onset (slopes > 0 by one-tailed t-tests, p < 0.05) and decreased after diabetes onset (slopes < 0 by one-tailed t-tests, p < 0.05). Diabetes resulted in increased plasma triglyceride levels (i) in recently diabetic relative to non-diabetic 14 week old early overnutrition males. Box and whisker plots (b,c,d,i) represent the interquartile range (box) and minimum to maximum values (whiskers), with line at the median. Data in panels c through h are from 5 early overnutrition male mice that developed diabetes, with color assignment per mouse matched for panels e through h. Scale bar = 50 µm.

Early Overnutrition and Islet Morphology

Islets from non-diabetic early overnutrition and non-diabetic control mice generally exhibited similar and normal morphology (Fig. 5a,b), although insulin immunoreactivity in early overnutrition islets tended to be more heterogeneous, with cell staining typically ranging from faint to intense within the same islet. To determine whether the observed reduction in Pdx1 gene expression in early overnutrition mice translated to reduced Pdx1 content in β cells, we co-stained pancreas sections with insulin and Pdx1. Pdx1 staining had the expected nuclear localization (Fig. 5c,d,i) in 3 of 5 non-diabetic control mice, with cytoplasmic or not detectable staining in the other two. In contrast, non-diabetic early overnutrition mice did not exhibit nuclear Pdx1 staining and instead had either predominantly cytoplasmic (Fig. 5e,f,i) or undetectable staining (Fig. 5g,h,i). Insulin immunoreactivity was reduced in P100 diabetic early overnutrition and control mice (Fig. 6a,b) and there was notable fibrosis surrounding and within islets (Fig. 6c,d). We observed no signs of immune cell infiltration (insulitis, peri-insulitis) in the pancreas of non-diabetic, pre-diabetic, or diabetic mice by examination of H&E stained sections or by immunofluorescence, using CD45 as a general immune cell marker and CD3 as a T-cell specific marker (data not shown). This suggests that the loss of β cells in these mice is not due to autoimmune attack. Immunofluorescence staining for known markers of β cell dedifferentiation, Aldh1a3 and L-myc31,32, resulted in negligible immunoreactivity in islets of pre-diabetic and diabetic mice (data not shown), suggesting that the loss of insulin staining is not due to dramatic dedifferentiation of β cells.

Figure 5
figure5

Islet morphology and Pdx1 in non-diabetic mice. Insulin (red) and glucagon (green) staining in non-diabetic control (a) and non-diabetic early overnutrition (b) mice at P100, demonstrating similar islet morphology (white: DAPI). Pdx1 staining (green) in a P100 non-diabetic control mouse (c) and Pdx1 (green) merged with insulin (red) (d) showing predominantly nuclear localization of Pdx1. P100 non-diabetic early overnutrition mice showing (e,f) mainly cytoplasmic staining of Pdx1 (green) colocalized with insulin in red, or non-detectable Pdx1 (g) and colocalization with insulin in red (h). All early overnutrition mice exhibited either cytoplasmic or non-detectable Pdx1 immunoreactivity (i), quantified as the predominant Pdx1 localization observed in each of 5 mice per group. Scale bars = 100 µm.

Figure 6
figure6

Islet morphology in diabetic mice. DAB-labelled insulin with an H&E counterstain demonstrated abundant insulin staining in a control non-diabetic mouse (a) and weaker and significant loss of insulin staining in a diabetic early overnutrition mouse (b). Masson’s trichrome stain in a non-diabetic control mouse (c) and a diabetic early overnutrition mouse (d) showing fibrosis, indicated by collagen staining in blue. All mice were 100 days of age. DAB: 3,3′-diaminobenzidine. Scale bars = 500 µm.

High-Fat Diet and Early Overnutrition

To investigate whether dietary fat content influenced the effects of early overnutrition on β cell function, we compared early overnutrition and control males whose mothers were fed either LFD or HFD throughout lactation with offspring weaned onto the same diet (LFD and HFD groups). In addition, to investigate the effects of increased dietary fat that was limited to the preweaning period, a subset of mice weaned from dams on HFD were switched LFD for the remainder of their life (HL group). Early overnutrition male pups, from dams consuming either LFD or HFD during lactation, exhibited significantly increased body weight relative to their control male counterparts, beginning at P10 through weaning at P21 (Fig. 7a). At P50, early overnutrition LFD males maintained a higher body weight relative to control LFD mice; however, in mice switched from HFD to LFD at weaning (HL group), and in mice remaining on HFD, body weight no longer differed between early overnutrition and control mice (Fig. 7b). Fasting glucose (Fig. 7c) was significantly lower in early overnutrition LFD vs control LFD mice with no difference in HL or HFD-fed mice. Fasting insulin levels (Fig. 7d) did not differ between early overnutrition and control mice within any dietary condition. HFD promoted the development of diabetes and this was exacerbated by early overnutrition, such that diabetes incidence was induced in a subset of early overnutrition HFD, control HFD, and early overnutrition HL mice, whereas LFD prevented diabetes in both early overnutrition and control (Fig. 7e). During an oral glucose tolerance test (Fig. 7f–i), glucose responses did not differ between early overnutrition and control mice, but insulin responses were lower in early overnutrition LFD relative to control LFD. Overall, insulin responses did not exhibit the expected significant rise in response to glucose, suggesting either general dysregulation of insulin secretion in all groups or selection of inappropriate sampling timepoints that did not capture the peak of glucose-stimulated insulin secretion. During insulin tolerance tests at P69 (Fig. 7j,l), glucose responses did not differ between early overnutrition and control mice. A second insulin tolerance test performed at P197 in LFD-fed mice only (Fig. 7k,l) showed that both control and early overnutrition mice maintained insulin sensitivity. HFD-fed mice could not be included at this age since many had been euthanized at an earlier age due to diabetes.

Figure 7
figure7

High-fat diet and early overnutrition. Body weight in male pups (a) maintained on LFD or HFD from postnatal day (2) to weaning at P21 (control LFD n = 5, early overnutrition LFD n = 4, control HFD n = 12, early overnutrition HFD n = 12). P50 body weight (b), fasting blood glucose (c), and fasting insulin (d) in control and early overnutrition males maintained on either LFD or HFD throughout life or switched from HFD to LFD at P21 (HL group). Diabetes incidence (e) to 23 weeks of age. Blood glucose response (f), glucose AUC (g), plasma insulin response (h), and insulin AUC (i) after gavage of 2 g/kg of glucose in 6 hr fasted mice at P121. Blood glucose response normalized to baseline (j) and glucose AUC (l, left side) in response to intraperitoneal injection of 0.75 U/kg insulin in 4 hr fasted mice at P69. Blood glucose response normalized to baseline (k) and glucose AUC (l, right side) in response to intraperitoneal injection of 0.75 U/kg insulin in 4 hr fasted control LFD and early overnutrition LFD mice at P197. Line graphs (a,f,h,j,k) represent the median ± interquartile range. Box and whisker plots (b,c,d,g,i) represent the interquartile range (box) and minimum to maximum values (whiskers), with line at the median. Floating bars (l) represent the range of values with line at the median. LFD: low fat (10%) diet; HFD: high fat (45%) diet beginning at P2; AUC: area under the curve with baseline = 0. *p < 0.05, **p < 0.005, ***p < 0.0005 for early overnutrition LFD vs control LFD by two-way repeated measures ANOVA (a) or unpaired t-test with Bonferroni correction for multiple comparisons (b,c,i); †††p < 0.0005 for early overnutrition HFD vs control HFD by two-way repeated measures ANOVA (a).

Discussion

We have demonstrated that overnutrition and increased dietary fat in early life can promote the development of diabetes. In Swiss Webster male mice, this diabetes is characterized by reduced Pdx1 expression and β cell dysfunction, in the absence of insulin resistance even in HFD-fed mice, that progresses to β cell death. In contrast, female mice maintained normoglycemia throughout life. Since litter size reduction in other rodent strains does not typically induce such profound β cell death, Swiss Webster mice likely have a genetic susceptibility to β cell dysfunction and diabetes. Our findings suggest that the nutritional environment during early life may impact long-term β cell function and increase the risk of diabetes, particularly in genetically susceptible individuals.

As previous studies have shown17,20,22, we observed accelerated weight gain in both early overnutrition males and females with reduced litter size, as well as hyperinsulinemia and hyperleptinemia, relative to their control counterparts. We also observed elevated β cell mass relative to controls in males, even when normalized to body weight. Slightly heavier body weight, higher adiposity, as well as disproportionally higher β cell mass persisted into adulthood in early overnutrition males. Despite higher β cell mass and more islets in adult early overnutrition compared to control males, total pancreas insulin content did not differ, likely due to the reduced insulin content per islet. Although isolated islets from early overnutrition males responded normally to a short-term exposure to high glucose and KCl, the low insulin reserves per islet are likely insufficient to respond to prolonged stimulants, such as chronic HFD, making them more susceptible to β cell failure.

We observed a high rate of overt diabetes in Swiss Webster males, with higher incidence in early overnutrition compared to control males. Diabetes was not observed in females, despite experiencing a similar acceleration in body growth in early life. A previous study also observed diabetes in male, but not female, Swiss Webster mice, in a colony selectively bred for diabetes susceptibility33. The reason for this sexual dimorphism is unclear; however, estrogens are known to have protective effects against the development of diabetes by increasing β cell insulin content34, increasing insulin sensitivity35,36, and protecting against β cell apoptosis37. Young, non-diabetic early overnutrition males exhibited increased plasma triglyceride levels, suggesting dysregulated lipid homeostasis. However, glucose tolerance and insulin tolerance did not differ significantly from control males. This suggests that the β cell dysfunction in these mice is not secondary to obesity-induced insulin resistance, as often occurs in mouse models in response to chronic HFD exposure.

The reduced Pdx1 expression that was observed in young early overnutrition males and the later development of low islet insulin content, suggests a primary β cell dysfunction induced by early overnutrition. This occurred despite the rapid β cell mass expansion observed in early overnutrition pups. Interestingly, the decrease in Pdx1 expression occurred prior to changes in insulin expression. Pdx1 is a key transcription factor required for normal pancreas development38,39,40. In humans, mutations in the PDX1 gene can lead to maturity onset diabetes of the young41, and reduced Pdx1 levels in mice have been shown to increase β cell susceptibility to apoptosis and HFD-induced ER stress38,42. Previous studies found that IUGR results in progressive reduction in Pdx1 levels due to epigenetic silencing, and the increased diabetes incidence in this model could be prevented by treatment in early life with exendin-4 that increases Pdx143,44, suggesting that reduced Pdx1 during development can induce diabetes. Thus, reduced Pdx1 levels in early overnutrition mice could be an early contributor to β cell dysfunction and render them more susceptible to metabolic stressors. The marginally reduced Neurod1 expression could also contribute to this dysfunction, since both Pdx1 and NeuroD1 act in concert to regulate insulin expression45. Predominantly cytoplasmic localization of Pdx1, as observed in some early overnutrition mice, has previously been observed in rats exposed to high glucose and lipids46, and after 8 weeks of consuming 58% HFD in C57BL/6J mice47. Reduced Pdx1 expression and immunoreactivity were observed at an age when early overnutrition mice did not exhibit differential glucose levels relative to control. Since elevated plasma triglycerides were observed in young early overnutrition males, it is possible that elevated lipid, but not glucose, levels may have contributed to the observed cytoplasmic Pdx1 localization. Although we did not detect increased expression of genes implicated in β cell lipotoxicity in young, non-diabetic early overnutrition mice, it may be that lipotoxic effects occurred at a later age.

The rise in plasma miR-375 levels observed in Swiss Webster mice prior to diabetes onset is indicative of β cell death, since dying β cells release miR-375 into the circulation29. The increased cleaved caspase-3 in β cells of diabetic mice suggests that cell death is at least in part due to apoptosis. In addition, the presence of fibrosis in and around islets is likely a consequence of this cell loss. Since mice developed diabetes at different ages, to better understand the progression of diabetes we tracked individual mice relative to diabetes onset. This revealed a progressive increase in insulin and proinsulin levels leading up to diabetes onset, suggestive of worsening β cell function. A progressive decrease in insulin and proinsulin occurred following diabetes onset and was therefore associated with hyperglycemia and increased β cell death. The susceptibility to overnutrition-induced β cell death in Swiss Webster mice makes this strain a useful model to study progression to diabetes, relative to the more commonly used C57BL/6 mice that exhibit relatively low rates of measurable β cell death on HFD despite developing obesity, hyperglycemia, and insulin resistance48,49. Indeed, a low dose of the β cell toxin streptozotocin is often combined with HFD in C57BL/6 mice to better mimic the β cell death that occurs in humans with type 2 diabetes50.

To investigate the role of dietary fat intake on diabetes susceptibility and its interaction with early overnutrition, control and early overnutrition offspring were raised either on HFD or LFD. HFD-feeding induced diabetes in both control and early overnutrition mice, whereas LFD was completely protective. In fact, early overnutrition mice maintained on LFD throughout life had improved glucose tolerance despite having a heavier body weight than control LFD mice, suggesting that early overnutrition could even be beneficial as long as dietary fat is kept low. HFD exposure only during the preweaning period prevented these beneficial effects of early overnutrition, suggesting that the preweaning period is a critical time of susceptibility to early overnutrition and dietary fat-induced β cell dysfunction. Whereas total fat content of milk remains high regardless of the mother’s level of dietary fat intake, the composition of fatty acids in milk varies to reflect that in the diet51. The HFD we employed had a higher proportion of saturated (mainly palmitic and stearic acids) and monounsaturated (mainly oleic acid) fatty acids compared to the LFD. Previous studies have observed that β cells are particularly sensitive to prolonged elevations in saturated fatty acids, with chronic palmitate exposure resulting in impaired β cell function including decreased Pdx1 expression and increased ER stress52,53,54. Our studies suggest that increased exposure to saturated and/or monounsaturated fatty acids specifically during the early postnatal period may have long-term detrimental effects on β cell function.

In a previous study, reduced litter size in Swiss Webster males did not result in overt diabetes and β cell death, and instead mice were more prone to HFD-induced obesity and insulin resistance20. However, these mice were of different origin from a different vendor (Simonsen Laboratories Gilroy, CA), so may not have the same genetic susceptibility or microbiome composition as the mice in the present study. Alternatively, since HFD in the previous study began at 6 weeks of age instead of shortly after birth, moderate to high dietary fat intake during the early postnatal period, as in the present study, is required to see the detrimental effects on β cell function that lead ultimately to β cell death in the absence of insulin resistance. This is supported by the increased diabetes incidence observed in early overnutrition offspring exposed to HFD only during the preweaning period.

Swiss Webster mice appear to have a genetic susceptibility that predisposes them to diabetes, induced by metabolic challenges such as overnutrition and increased dietary fat in early life, during the period of rapid β cell mass expansion. Despite an early increase in β cell mass induced by early overnutrition, the β cell dysfunction reflected in the reduced islet insulin content and reduced Pdx1 expression eventually leads to β cell death. Our findings may offer insight into potential detrimental effects that could occur in humans, particularly those with a genetic susceptibility for primary β cell dysfunction, resulting in adverse consequences from overnutrition in infancy and/or childhood. A better understanding of the underlying mechanisms mediating the development of β cell dysfunction in the Swiss Webster mouse, and the time frame in which they occur, may help us identify at-risk children that show a similar susceptibility, allowing for early interventions aimed at preventing long-term adverse outcomes.

Methods

Animals and Tissue Harvest

Mice were housed under a 12-hr light, 12-hr dark cycle (lights on at 0700 h), with constant temperature and humidity and ad libitum access to food and water. Pregnant (16–17d) Swiss Webster mice (Model #SW-F) were purchased from Taconic (Hudson, NY) and maintained on a moderate fat (26.1 kcal% fat) standard chow diet (5LJ5 diet, Lab Diet, St. Louis, MO). Two days post-delivery, litters were culled to 10 pups for the control group. For the early overnutrition group, litters were initially culled to 6 pups at P2, and then further culled to 3 pups at P5. This stepwise reduction in litter size reduces the chances of insufficient maternal milk production. Groups were assigned such that pup body weights did not differ between control and early overnutrition groups at P2. Pups were weaned onto the same diet as the mother (5LJ5). For the HFD study, pregnant Swiss Webster mice purchased from Taconic were placed on 10 kcal% low-fat diet (LFD; D12450B, Research Diets, Inc, New Brunswick, NJ). Two days post-delivery, dams were either maintained on LFD or switched to 45 kcal% lard-based HFD (D12451, Research Diets, Inc.), with litters culled as above. All offspring were weaned at P21, with mice from the LFD and HFD groups maintained on the same diet as their mother throughout life. To examine long-term effects of HFD that was limited to the preweaning period, a subset of mice weaned from HFD-fed dams was switched to LFD at P21 (HL group).

Since only male Swiss Webster mice developed diabetes, detailed metabolic assessments in adults were performed only in male mice. Adult tissue collection was performed after a 4 hr fast (0900 h to 1300 h) and all tissues were weighed immediately upon dissection. Pup tissue and trunk blood collection was performed in the AM in non-fasted male mice after isoflurane anesthesia. Tissues for immunohistochemistry and histology were post-fixed in 4% paraformaldehyde followed by paraffin-embedding and sectioning at 5 µm by Wax-It Histology Services Inc. (Vancouver, Canada). For total pancreas insulin content, whole pancreas was incubated in −20 °C 0.18 M HCl/70% ethanol, homogenized, then incubated again at −20 °C overnight. Following centrifugation, the aqueous solution was neutralized 1:2 with 1 M Tris, pH 7.5. All procedures with animals were approved by the University of British Columbia Animal Care Committee and carried out in accordance with the Canadian Council of Animal Care guidelines.

Metabolic Assessments

Blood glucose values were determined with a OneTouch Ultra 2 glucometer (LifeScan, Inc., Burnaby, Canada) measured from saphenous vein blood. Fasting (4 hr) glucose and body weight were monitored weekly beginning at P30-35. Diabetes onset was defined as the first day of two consecutive fasting glucose measures ≥ 20 mM (or ≥ 15 mM for the miR-375 analysis study to match previous study)29. Food intake (averaged over 7 days) was measured in individually housed mice (aged P60 to 80) by weighing food hoppers daily. For glucose tolerance tests, 6 hr fasted mice were given 2 g/kg glucose either by intraperitoneal injection or oral gavage, and blood collected prior to glucose administration and at indicated times after injection into heparin-coated capillary tubes. For insulin tolerance tests, 4 hr fasted mice were injected intraperitoneally with 0.75 U/kg insulin (Novolin ge Toronto, Novo Nordisk Canada, Mississauga, Canada), with glucose measures conducted at 0, 10, 20, 30, 60, 90, and 120 min post-injection. For assessment of circulating miR-375 levels, ~100 µL of blood was collected from the saphenous vein into EDTA-coated capillary tubes. This was performed once per week, beginning at P32, in early overnutrition males maintained on 5LJ5 diet. Plasma was stored at −80 °C prior to RNA isolation.

Islet Isolation

Islets were isolated as previously described55 using Type XI collagenase (1000 units/mL; #C7657, Sigma-Aldrich, St. Louis, MO) injected into the pancreatic duct. Following digestion and filtration, islets were picked with a pipette in three rounds to remove any remaining acinar tissue. For islet RNA isolation, ~100 islets per mouse were placed in a 1.5 mL tube and spun down at 200 x g for 1 min. Excess buffer was removed and then islets were homogenized in 600 µL RLT Buffer (Qiagen, Hilden, Germany) using a 1 mL syringe with a 21 gauge 1” needle. Tubes were then frozen on dry ice and stored at −80 °C for RNA isolation.

Islet perifusions were performed as previously described38. Briefly, 80 size-matched islets per mouse were perifused with a HEPES-buffered Krebs-Ringer buffer under temperature and CO2-controlled conditions. Perifusate was collected every 5 min under basal glucose (3 mM), high glucose (20 mM), and 30 mM KCl conditions, and insulin secretion analyzed by radioimmunoassay. For islet insulin content, 5 islets per mouse were acid-ethanol extracted as described above and stored at −20 °C.

Pancreas Immunohistochemistry and Histology

All primary antibodies and dilutions used for immunohistochemistry are listed in Supplementary Table S1. For immunofluorescence staining, slides were deparaffinized and hydrated in xylene washes followed by graded ethanol washes. Slides were then washed in phosphate-buffered saline (PBS) followed by 10–15 min incubation in 10 mM sodium citrate/0.05% Tween 20, pH 6.0 at 95 °C. After cooling, slides were incubated for 10 min with DAKO Protein Block Serum-Free (Agilent Technologies, Inc, Santa Clara, CA) at room temperature and then overnight at 4 °C with primary antibody diluted in Dako Antibody Diluent (Agilent Technologies, Inc.). Following washes in PBS, slides were incubated in Alexa Fluor 488 or 594 secondary antibodies (Thermo Fisher Scientific, Waltham, MA) diluted in Dako Antibody Diluent and then washed in PBS. Slides were coverslipped with VECTASHIELD HardSet Mounting Medium with DAPI (Vector Laboratories, Burlingame, CA). Images were captured with the ImageXpress Micro High-Content Imaging system and MetaXpress 5.3.0.5 software (Molecular Devices, Sunnyvale, CA). For chromogenic staining of insulin, the procedure was as above on day 1 with the addition of a 12 min incubation in 3% H2O2 and 10 min PBS wash prior to the blocking step. On day 2, following washes in PBS, slides were incubated in biotinylated anti-guinea pig IgG (1:200, Jackson ImmunoResearch, West Grove, PA) diluted in Dako Antibody Diluent, for 1 hr at room temperature in a humid chamber. Slides were then washed in PBS, incubated for 30 min with R.T.U. VECTASTAIN ABC Reagent (Vector Laboratories), washed for 10 min in PBS, then incubated in 3,3′-diaminobenzidine (DAB) Peroxidase (HRP) Substrate solution (Vector Laboratories). Slides were counterstained with hematoxylin and eosin (H&E), dehydrated through a graded ethanol and xylene series, and then coverslipped with Vectamount Permanent Mounting Medium (Vector Laboratories).

β cell mass was analyzed in three pancreas sections per mouse, at least 200 µm apart, on insulin-DAB stained sections for P14 pups and immunofluorescent insulin-labeled sections in adults. Image threshold was set such that weak insulin staining within an islet was considered positive. Islet size was quantified as the insulin-positive area per islet. H&E staining and Masson’s trichrome staining on adult pancreas sections were performed by Wax-it Histology Services Inc. (Vancouver, Canada).

RNA Isolation and quantitative RT-PCR

Total RNA was isolated from islets using the Qiagen RNeasy Mini Kit as per the manufacturer’s instructions, and reverse transcribed with iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA). Quantitative RT-PCR was performed using Ssofast EvaGreen Supermix (Bio-Rad) with Hprt1 as the reference gene, or TaqMan Fast Universal PCR Master Mix for Ins1 and Ins2 (Applied Biosystems) with mouse β-actin (4352341E, Thermo Fisher Scientific) as a reference gene, in a StepOnePlus real-time PCR system (Applied Biosystems, Foster City, CA). Transcript levels were quantified by the 2−ΔΔCT method. All primer sequences are listed in Supplementary Table S2.

For miR-375 measurement in the circulation, extracellular RNA was isolated from plasma samples in the presence of an MS2 carrier RNA (Roche, Laval, Canada) using the Qiagen miRNeasy Kit. Reverse transcription was performed with the Universal cDNA Synthesis Kit II (Exiqon, Vedbaek, Denmark). Quantitative RT-PCR was performed using the ExILENT SYBR Green Master Mix (Exiqon) with LNA-based miRNA primers (Exiqon). Relative values were calculated with the ΔCT method using miR-16* as a reference miRNA.

Assays

Insulin was measured in plasma, pancreas, and islets using the Mouse Ultrasensitive Insulin ELISA (ALPCO, Salem, NH). Insulin from perifusions was measured with the Rat Insulin RIA (Millipore, Billerica, MA). Proinsulin (Rat/Mouse Proinsulin ELISA, Mercodia AB, Uppsala, Sweden), leptin (Mouse Leptin ELISA Kit, Crystal Chem, Downers Grove, IL), and triglycerides (Serum Triglyceride Determination Kit, Sigma-Aldrich) were measured in plasma.

Statistical analyses

Statistical analyses were performed using GraphPad Prism 7, with significance defined as p < 0.05. For the HFD study, all statistical comparisons were done within dietary condition. Area under the curve (AUC) measurements were conducted with the baseline set to a value of 0. Statistical tests are detailed in figure legends. T-tests were used for normally distributed data (two-tailed, unpaired unless otherwise stated in the figure legend). Bonferroni correction was used to correct for multiple comparisons, where applicable. Nonparametric tests (Mann-Whitney) were used for any data that did not pass the Shapiro-Wilk test for normality. Continuous data are represented by line graphs with median ± interquartile (IQR) range, and categorical data are represented by box and whisker plots. Where a panel contains a group with n = 3, floating bars represent the range of values and the line is at the median. For box and whisker plots and floating bar graphs, all individual data points are shown. For line graphs that show no indication of sample size such as a corresponding AUC graph, sample size is provided in the figure legend.

References

  1. 1.

    Leunissen, R. W., Kerkhof, G. F., Stijnen, T. & Hokken-Koelega, A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA 301, 2234–2242 (2009).

    CAS  Article  Google Scholar 

  2. 2.

    Nobili, V., Alisi, A., Panera, N. & Agostoni, C. Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. Pediatr Endocrinol Rev 6, 241–247 (2008).

    PubMed  Google Scholar 

  3. 3.

    Dulloo, A. G., Jacquet, J., Seydoux, J. & Montani, J. P. The thrifty ‘catch-up fat’ phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. Int J Obes (Lond) 30(Suppl 4), S23–35 (2006).

    CAS  Article  Google Scholar 

  4. 4.

    Barker, D. J. The developmental origins of insulin resistance. Horm Res 64(Suppl 3), 2–7 (2005).

    CAS  PubMed  Google Scholar 

  5. 5.

    Whincup, P. H. et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 300, 2886–2897 (2008).

    CAS  Article  Google Scholar 

  6. 6.

    Patel, M. S. & Srinivasan, M. Metabolic programming due to alterations in nutrition in the immediate postnatal period. J Nutr 140, 658–661 (2010).

    CAS  Article  Google Scholar 

  7. 7.

    Dorner, G. & Plagemann, A. Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life. Horm Metab Res 26, 213–221 (1994).

    CAS  Article  Google Scholar 

  8. 8.

    Hanson, M. A. & Gluckman, P. D. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev 94, 1027–1076 (2014).

    CAS  Article  Google Scholar 

  9. 9.

    Poston, L. Developmental programming and diabetes - The human experience and insight from animal models. Best Pract Res Clin Endocrinol Metab 24, 541–552 (2010).

    Article  Google Scholar 

  10. 10.

    Kanaka-Gantenbein, C. Fetal origins of adult diabetes. Ann N Y Acad Sci 1205, 99–105 (2010).

    ADS  Article  Google Scholar 

  11. 11.

    Plagemann, A. A matter of insulin: developmental programming of body weight regulation. J Matern Fetal Neonatal Med 21, 143–148 (2008).

    CAS  Article  Google Scholar 

  12. 12.

    Dunger, D. B., Salgin, B. & Ong, K. K. Session 7: Early nutrition and later health early developmental pathways of obesity and diabetes risk. Proc Nutr Soc 66, 451–457 (2007).

    CAS  Article  Google Scholar 

  13. 13.

    Bjerregaard, L. G. et al. Change in Overweight from Childhood to Early Adulthood and Risk of Type 2 Diabetes. N Engl J Med 378, 1302–1312 (2018).

    Article  Google Scholar 

  14. 14.

    Meier, J. J. et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 57, 1584–1594 (2008).

    CAS  Article  Google Scholar 

  15. 15.

    Georgia, S. & Bhushan, A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114, 963–968 (2004).

    CAS  Article  Google Scholar 

  16. 16.

    Plagemann, A. et al. Observations on the orexigenic hypothalamic neuropeptide Y-system in neonatally overfed weanling rats. J Neuroendocrinol 11, 541–546 (1999).

    CAS  Article  Google Scholar 

  17. 17.

    Wiedmer, P., Klaus, S. & Ortmann, S. Energy metabolism of young rats after early postnatal overnutrition. Br J Nutr 88, 301–306 (2002).

    CAS  Article  Google Scholar 

  18. 18.

    Boullu-Ciocca, S., Achard, V., Tassistro, V., Dutour, A. & Grino, M. Postnatal programming of glucocorticoid metabolism in rats modulates high-fat diet-induced regulation of visceral adipose tissue glucocorticoid exposure and sensitivity and adiponectin and proinflammatory adipokines gene expression in adulthood. Diabetes 57, 669–677 (2008).

    CAS  Article  Google Scholar 

  19. 19.

    Xiao, X. Q. et al. Excess weight gain during the early postnatal period is associated with permanent reprogramming of brown adipose tissue adaptive thermogenesis. Endocrinology 148, 4150–4159 (2007).

    CAS  Article  Google Scholar 

  20. 20.

    Glavas, M. M. et al. Early overnutrition results in early-onset arcuate leptin resistance and increased sensitivity to high-fat diet. Endocrinology 151, 1598–1610 (2010).

    CAS  Article  Google Scholar 

  21. 21.

    Koldovsky, O., Hahn, P., Hromadova, M., Krecek, J. & Macho, L. Late effects of early nutritional manipulations. Physiol Res 44, 357–360 (1995).

    CAS  PubMed  Google Scholar 

  22. 22.

    You, S., Gotz, F., Rohde, W. & Dorner, G. Early postnatal overfeeding and diabetes susceptibility. Exp Clin Endocrinol 96, 301–306 (1990).

    CAS  Article  Google Scholar 

  23. 23.

    Meng, Z. X. et al. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines. Diabetologia 55, 1733–1744 (2012).

    CAS  Article  Google Scholar 

  24. 24.

    Joseph, J. W. et al. Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J Biol Chem 279, 51049–51056 (2004).

    CAS  Article  Google Scholar 

  25. 25.

    Chen, E. et al. PLIN2 is a Key Regulator of the Unfolded Protein Response and Endoplasmic Reticulum Stress Resolution in Pancreatic beta Cells. Sci Rep 7, 40855 (2017).

    ADS  CAS  Article  Google Scholar 

  26. 26.

    Laybutt, D. R. et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50, 752–763 (2007).

    CAS  Article  Google Scholar 

  27. 27.

    Michalska, M., Wolf, G., Walther, R. & Newsholme, P. Effects of pharmacological inhibition of NADPH oxidase or iNOS on pro-inflammatory cytokine, palmitic acid or H2O2-induced mouse islet or clonal pancreatic beta-cell dysfunction. Biosci Rep 30, 445–453 (2010).

    CAS  Article  Google Scholar 

  28. 28.

    Duan, W. R. et al. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199, 221–228 (2003).

    CAS  Article  Google Scholar 

  29. 29.

    Erener, S., Mojibian, M., Fox, J. K., Denroche, H. C. & Kieffer, T. J. Circulating miR-375 as a biomarker of beta-cell death and diabetes in mice. Endocrinology 154, 603–608 (2013).

    CAS  Article  Google Scholar 

  30. 30.

    Song, I., Roels, S., Martens, G. A. & Bouwens, L. Circulating microRNA-375 as biomarker of pancreatic beta cell death and protection of beta cell mass by cytoprotective compounds. PLoS One 12, e0186480 (2017).

    Article  Google Scholar 

  31. 31.

    Talchai, C., Xuan, S., Lin, H. V., Sussel, L. & Accili, D. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150, 1223–1234 (2012).

    CAS  Article  Google Scholar 

  32. 32.

    Kim-Muller, J. Y. et al. Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic beta cells in diabetic mice. Nature communications 7, 12631 (2016).

    ADS  CAS  Article  Google Scholar 

  33. 33.

    Lemke, L. B., Rogers, A. B., Nambiar, P. R. & Fox, J. G. Obesity and non-insulin-dependent diabetes mellitus in Swiss-Webster mice associated with late-onset hepatocellular carcinoma. J Endocrinol 199, 21–32 (2008).

    CAS  Article  Google Scholar 

  34. 34.

    Alonso-Magdalena, P. et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 3, e2069 (2008).

    ADS  Article  Google Scholar 

  35. 35.

    Bryzgalova, G. et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49, 588–597 (2006).

    CAS  Article  Google Scholar 

  36. 36.

    Brussaard, H. E., Gevers Leuven, J. A., Frolich, M., Kluft, C. & Krans, H. M. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40, 843–849 (1997).

    CAS  Article  Google Scholar 

  37. 37.

    Le May, C. et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 103, 9232–9237 (2006).

    ADS  Article  Google Scholar 

  38. 38.

    Johnson, J. D. et al. Increased islet apoptosis in Pdx1+/− mice. J Clin Invest 111, 1147–1160 (2003).

    CAS  Article  Google Scholar 

  39. 39.

    Brissova, M. et al. Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 277, 11225–11232 (2002).

    CAS  Article  Google Scholar 

  40. 40.

    Iype, T. et al. Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1: application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes. J Biol Chem 280, 16798–16807 (2005).

    CAS  Article  Google Scholar 

  41. 41.

    Stoffers, D. A., Ferrer, J., Clarke, W. L. & Habener, J. F. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17, 138–139 (1997).

    CAS  Article  Google Scholar 

  42. 42.

    Sachdeva, M. M. et al. Pdx1 (MODY4) regulates pancreatic beta cell susceptibility to ER stress. Proc Natl Acad Sci USA 106, 19090–19095 (2009).

    ADS  CAS  Article  Google Scholar 

  43. 43.

    Park, J. H., Stoffers, D. A., Nicholls, R. D. & Simmons, R. A. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 118, 2316–2324 (2008).

    CAS  Article  Google Scholar 

  44. 44.

    Pinney, S. E., Jaeckle Santos, L. J., Han, Y., Stoffers, D. A. & Simmons, R. A. Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat. Diabetologia 54, 2606–2614 (2011).

    CAS  Article  Google Scholar 

  45. 45.

    Aramata, S., Han, S. I., Yasuda, K. & Kataoka, K. Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1. Biochim Biophys Acta 1730, 41–46 (2005).

    CAS  Article  Google Scholar 

  46. 46.

    Hagman, D. K. et al. Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets. Diabetes 57, 424–431 (2008).

    CAS  Article  Google Scholar 

  47. 47.

    Reimer, M. K. & Ahren, B. Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes 51(Suppl 1), S138–143 (2002).

    CAS  Article  Google Scholar 

  48. 48.

    Peyot, M. L. et al. Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass. Diabetes 59, 2178–2187 (2010).

    CAS  Article  Google Scholar 

  49. 49.

    Surwit, R. S., Kuhn, C. M., Cochrane, C., McCubbin, J. A. & Feinglos, M. N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37, 1163–1167 (1988).

    CAS  Article  Google Scholar 

  50. 50.

    Gilbert, E. R., Fu, Z. & Liu, D. Development of a nongenetic mouse model of type 2 diabetes. Experimental diabetes research 2011, 416254 (2011).

    Article  Google Scholar 

  51. 51.

    Silverman, J., Stone, D. W. & Powers, J. D. The lipid composition of milk from mice fed high or low fat diets. Lab Anim 26, 127–131 (1992).

    CAS  Article  Google Scholar 

  52. 52.

    Ryu, G. R. et al. Decreased Expression and Induced Nucleocytoplasmic Translocation of Pancreatic and Duodenal Homeobox 1 in INS-1 Cells Exposed to High Glucose and Palmitate. Diabetes & metabolism journal 35, 65–71 (2011).

    Article  Google Scholar 

  53. 53.

    Cnop, M. et al. RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate. Diabetes 63, 1978–1993 (2014).

    CAS  Article  Google Scholar 

  54. 54.

    Karaskov, E. et al. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 147, 3398–3407 (2006).

    CAS  Article  Google Scholar 

  55. 55.

    Salvalaggio, P. R. et al. Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 74, 877–879 (2002).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We thank Dr. Cara E. Ellis for advice on statistical analyses and data visualization, and Betty Hu for technical assistance. This work was supported by a grant from the Canadian Institutes of Health Research and a fellowship (M.M.G.) from the Canadian Diabetes Association.

Author information

Affiliations

Authors

Contributions

M.M.G., Q.H., E.T., S.E. and N.L.K. conducted experiments. M.M.G. researched the data, performed statistical analyses, and wrote the manuscript. M.M.G., J.D.J. and T.J.K. designed experiments. Q.H., E.T., S.E., N.L.K., J.D.J. and T.J.K. contributed to discussion and reviewed/edited the manuscript.

Corresponding author

Correspondence to Timothy J. Kieffer.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Glavas, M.M., Hui, Q., Tudurí, E. et al. Early overnutrition reduces Pdx1 expression and induces β cell failure in Swiss Webster mice. Sci Rep 9, 3619 (2019). https://doi.org/10.1038/s41598-019-39177-3

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing